Physician profile
David E Jonason
NPI 1730709643
$962.99
in general payments reported to CMS, 2019-2025
8 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $85.99 · 2024: $746 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879 · Education: $84.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.99 |
| Education | $84.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $395.61 | 2024 | Livdelzi, Vemlidy |
| Abbvie INC. | $207.25 | 2024 | |
| Novo Nordisk INC | $123.85 | 2024 | |
| Conmed Corporation | $85.99 | 2023 | Conmed Biliary, Conmed Hemostasis |
| Janssen Biotech, INC. | $84.00 | 2025 | Tremfya |
| Cook Medical LLC | $32.42 | 2025 | Cook |
| Medtronic, INC. | $19.04 | 2024 | Manoscan |
| Phathom Pharmaceuticals, INC. | $14.83 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jonason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.